Tango Therapeutics Inc.

NASDAQ: TNGX · Real-Time Price · USD
6.79
-0.13 (-1.88%)
At close: Aug 15, 2025, 3:59 PM
6.77
-0.29%
After-hours: Aug 15, 2025, 04:59 PM EDT

Tango Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-130.3M -101.74M -108.18M -58.23M
Depreciation & Amortization
2.5M 2.42M 1.61M 897K
Stock-Based Compensation
28.9M 19.08M 14.23M 7.83M
Other Working Capital
-30.56M -38.26M -19.59M -12.58M
Other Non-Cash Items
-849K 234K 1.75M 1.32M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-31.75M -37.97M -18.49M -11.35M
Operating Cash Flow
-131.5M -117.98M -109.08M -59.53M
Capital Expenditures
-754K -1.53M -7.69M -1.84M
Cash Acquisitions
n/a n/a -34.09M 181.6M
Purchase of Investments
-240.89M -310.57M -208.5M -372.36M
Sales Maturities Of Investments
327.77M 353.53M 242.59M 190.76M
Other Investing Acitivies
n/a n/a 34.09M -181.6M
Investing Cash Flow
86.13M 41.43M 26.4M -183.43M
Debt Repayment
n/a n/a n/a 342.11M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
5.94M 2.39M 1.61M -14.78M
Financial Cash Flow
47.66M 82.41M 1.61M 357.32M
Net Cash Flow
2.29M 5.85M -81.07M 114.36M
Free Cash Flow
-132.25M -119.51M -116.77M -61.36M